"Antiemetics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to prevent NAUSEA or VOMITING.
- Antiemetic Drugs
- Drugs, Antiemetic
- Anti emetics
- Antiemetic Agents
- Agents, Antiemetic
- Antiemetic Effect
- Effect, Antiemetic
- Anti-Emetic Effects
- Anti Emetic Effects
- Effects, Anti-Emetic
- Antiemetic Effects
- Effects, Antiemetic
- Anti-Emetic Effect
- Anti Emetic Effect
- Effect, Anti-Emetic
Below are MeSH descriptors whose meaning is more general than "Antiemetics".
Below are MeSH descriptors whose meaning is more specific than "Antiemetics".
This graph shows the total number of publications written about "Antiemetics" by people in this website by year, and whether "Antiemetics" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Antiemetics" by people in Profiles.
Avoidable Acute Care Use Associated with Nausea and Vomiting Among Patients Receiving Highly Emetogenic Chemotherapy or Oxaliplatin. Oncologist. 2021 04; 26(4):325-331.
What the HEC? Clinician Adherence to Evidence-Based Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy. J Natl Compr Canc Netw. 2020 06; 18(6):676-681.
Systemic hypersensitivity to fosaprepitant - A report of two cases. J Oncol Pharm Pract. 2018 Jan; 24(1):76-78.
Green urine in the intensive care unit: is this clinically relevant? Am Surg. 2015 Jan; 81(1):E32-3.
Antiemetic and sedative levels found together in 26 civil aviation pilot fatalities, 2000-2006. Aviat Space Environ Med. 2008 Jun; 79(6):607-10.
Management of opioid-induced gastrointestinal effects in patients receiving palliative care. Pharmacotherapy. 2002 Feb; 22(2):240-50.
Efficacy and safety of oral granisetron versus i.v. granisetron in patients undergoing peripheral blood progenitor cell and bone marrow transplantation. Anticancer Drugs. 2000 Feb; 11(2):137-42.